Brian Anderson

Assistant Clinical Professor

UCSF Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Brian Anderson is an Assistant Clinical Professor at UCSF Medical Center in the United States. His research focuses on psychedelics, including their therapeutic applications and community-oriented practices. Recent articles include topics such as the effects of hallucinogens, mental health assessments in medical aid in dying, and the integration of traditional knowledge in psychedelic therapy.

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Kelan LH Thomas

Professor

Touro University California

UNITED STATES

View details

Nicky Mehtani

University of California, San Francisco

UNITED STATES

View details

Meredith Meacham

University of California, San Francisco

UNITED STATES

View details

Theodore Satterthwaite

Associate Professor

University of Pennsylvania

UNITED STATES

View details

Petros Petridis

New York University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brian Anderson

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

A systematic review of income and education reporting in psychedelic clinical trials

Latent Classes of Lifetime Use of Seven Hallucinogens in the United States

Implementation of the California End of Life Option Act at UCSF: Examining the Utility of the Mandatory Mental Health Assessment in Medical Aid in Dying

On Minimizing Risk and Harm in the Use of Psychedelics

Older adults in psychedelic-assisted therapy trials: A systematic review

In Memoriam: Roland R. Griffiths (July 19, 1946–October 16, 2023)

Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics

Psychedelic Research and Therapeutic Practices: Embracing Communities, Groups, and Traditional Knowledge

Psychedelic Science, Contemplative Practices, and Indigenous and Other Traditional Knowledge Systems: Towards Integrative Community-Based Approaches in Global Health

If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics

Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis

Psychedelic medicine: safety and ethical concerns.

Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study

Collaborators (5)

Kelan LH Thomas

Nicky Mehtani

Meredith Meacham

Theodore Satterthwaite

Petros Petridis

Make your next move.